What can we do to Palliate Dyspnea? Steve Dupuis DO Faith Hospice Associate Medical Director.

Slides:



Advertisements
Similar presentations
DYSPNEA IN PALLIATIVE CARE
Advertisements

The Management of Incident Pain in Palliative Care.
Opioids and other drugs we use on palliative care
Asthma.
Breathlessness Barbara Mackie and Jo Lenton
Pulmonary Edema.
Mike Callihan RN,BSN, Paramedic, EMSI
Preparing for the Predictable Planning for common threats to comfort in the final days. Tamara Wells RN MN CNS Dr. M. Harlos Medical Director WRHA Palliative.
Opioid Pharmacology: How to choose and how to use Romayne Gallagher MD, CCFP Division of Palliative Providence Health Care.
SYMPTOM CONTROL FOR ADVANCED RESPIRATORY DISEASE
Chronic obstructive pulmonary disease (COPD) Dr. Walaa Nasr Lecturer of Adult Nursing Second year.
RESPIRATORY SYSTEM COMMON DISORDERS. DYSPNEA SYMPTOM THAT CAN BE CAUSED BY airway obstruction, hypoxia, pulmonary edema, lung diseases, heart conditions,
Key dosing points: Begin a bowel regimen when opioid therapy is initiated (senna + docusate). For CHRONIC pain, use a scheduled medication regimen. ( ex:
Treating Dyspnea in Advanced Cancer and E/S COPD Barb Supanich,RSM,MD,FAAHPM Holy Cross Palliative Care Medical Director April 8, 2010 Barb Supanich,RSM,MD,FAAHPM.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 05: Relieving Pain and Providing Comfort.
Procedural Sedation Pharmacology Deb Updegraff R.N., P.N.P, C.N.S. Clinical Nurse Specialist LPCH Pediatric Intensive Care Unit.
Drugs For Treating Asthma
The Palliation of Dyspnea in Far Advanced Lung Cancer Dr. Anna Towers Division of Palliative Care McGill University.
{ Management of Advanced Breathlessness Dr Phil Wilkins, Norfolk and Norwich University Hospital and Priscilla Bacon Lodge, Norwich.
Palliative Management of Dyspnea
The Final Hours of Life Michael GuntherMaher MD, FACP
The Prostate Net Pain Management for Patients and Caregivers Biren Saraiya MD The Cancer Institute of New Jersey.
The Prostate Net Pain management for patients and caregivers Biren Saraiya MD The Cancer Institute of New Jersey.
Palliative Medicine, Pain Management, and Hospice Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine.
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Anticholinergic (Parasympatholytic) Bronchodilators.
Managing Symptoms in Palliative Care. Aims  To gain an awareness of the most common symptoms in patients with life limiting diseases and why these occur.
Palliative Care: Shortness of Breath and Secretions Hong-Phuc Tran, M.D.
THE FINAL DAY(S) Keeping the Promise of Comfort.
End of Life Care Education Case Scenario 3 End of Life Care Webinar MODULE 1.
The Basics of Symptom Management: Understanding, Assessment and Principles Dr. Leah Steinberg.
Section 4: Medical Emergencies
The Role of the Respiratory Therapist in Hospice/Palliative Care Tim Buckley, RRT, FAARC Director Respiratory Services Walgreens Home Care.
Respiratory Equipment Most Often Used in Hospice Care Mark Schroedel, CRT Walgreens Home Care.
Sedation, Analgesia and Paralytics in the ICU
Drug Therapy Heart Failure by Pat Woodbery, MSN, ARNP.
End of Life Symptom Management Dec 3, 2014 Mudit Dabral Rosene Pirrello.
 72 M, acute femoral fracture. History of hip, knee OA. Uses Tylenol, ibuprofen.  Used Norco in the past very infrequently. Keeps an old bottle in the.
Common Symptoms at End of Life Stephanie Reynolds, MSN, NP, ACHPN Palliative Care, Jacobi Medical Center.
By Dr Marie Joseph MB BS FRCP Medical Director & Consultant in Palliative Medicine St Raphael’s Hospice, Surrey and Macmillan Consultant, Epsom & St Helier.
Bradford & Airedale Palliative Care Managed Clinical Network Last few days of life Symptom Control.
Dyspnea a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity derives from interactions.
EPECEPECEPECEPEC EPECEPECEPECEPEC Dyspnea Module 10c The Education in Palliative and End-of-life Care program at Northwestern University Feinberg School.
Acute Pain Management Solomon Liao, M.D. Clinical Professor Director of Palliative Care Service UCI Hospitalist Program.
Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab. DCA, Dip. Software statistics PhD (physio) Mahatma Gandhi Medical college and research institute,
5 mins on last days of life and palliative care emergencies ! Dr. Ros Taylor Hospice Director Hospice of St. Francis Berkhamsted June 2012.
Pediatric Palliative Care C C E E N N L L E E Neurological Autonomic dysregulation Dystonias Restlessness/agitation Seizure.
Pain II: Cancer Pain Management Dr. Leah Steinberg.
Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc.
Palliative Care: Non pain symptoms Elizabeth Whiteman, M.D.
Dr Barbara Downes June Introduction Patient group An over view of managing pain Revision of the basics Case examples Drugs and conversions in the.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
СOPD Chronic obstructive pulmonary disease (COPD), a common preventable and treatable disease, is characterized by persistent airflow limitation that.
Inadequately treated acute pain can lead to prolonged hospital stay, delayed recovery, psychological consequences, increased costs and the development.
What is Palliative Care? n Support and comfort for individuals and families living with chronic or life- threatening illnesses n Focuses on: –Relieving.
GP Clinical Governance Meeting 13 th of July 2011 Dr Marion Lieth Consultant in Palliative Medicine, Bolton Hospital and Bolton Hospice Common issues:
Care | Valued | Excellence | Innovation Breathlessness Clinic: a non- pharmacological approach Julie Southon, Specialist Nurse Supportive and Palliative.
MNA M osby ’ s Long Term Care Assistant Chapter 25 Oxygen Needs.
Opiod analgesics 9월 흉부외과 인턴 김영재.
Managementn of RespiratorySymptoms in Cancer Patients
Palliative Care in the Outpatient Setting: Pain Management
Addressing sleep problems- The role of long-acting opioids
Dyspnea & cough.
Opioids and other drugs we use in palliative care
Rachel Williams Clinical Specialist Respiratory Physiotherapist
Sarcoma Exchange 2018 Sarcoma Alliance
Polmunary edema.
TOTAL PULMONARY VENTILATION
COPD Exacerbations UCI Internal Medicine Mini-Lecture
Naloxone (Narcan) Induced Pulmonary Edema
Temple College EMS Professions
Presentation transcript:

What can we do to Palliate Dyspnea? Steve Dupuis DO Faith Hospice Associate Medical Director

Life is not measured by the number of breaths we take, but by the moments that take our breath away.... Anonymous

Objectives Review the common treatments that our colleagues have already tried Explore more creative modalities that our colleagues expect of us Share our expertise Create an update for WMMD manual

Dyspnea is not.... Tachypnea which is rapid breathing Hyperpnea which is increased ventilation in proportion to metabolism Hyperventilation which is ventilation in excess of metabolic requirement Comroe 1966

Dyspnea is instead…. ….difficult, labored, uncomfortable breathing; it is an unpleasant type of breathing, though it is not painful in the usual sense of the word. Comroe 1966

Dyspnea It is subjective, and like pain, it involves both the perception of the sensation by the patient and their reaction to the sensation…. Comroe 1966

Prevalence Reported to occur in 21-70% of all terminally ill patients National Hospice Study 25% patients experiencing breathlessness did not have underlying pulmonary diseases

Management

Oxygen Should be offered in any circumstance of dyspnea but no studies that show it to be any more effective than…. Environmental changes: Cool humidified air Circulating fan Fowler’s position Pursed lip breathing

Reassurance Calming, relaxation techniques Breathing exercises Music therapy Aromatherapy Social Work Chaplain

Nebs Duonebs q 3hrs & prn Decadron 4mgs q 4hrs For Pulmonary Edema 4 mls 50% Ethyl Alcohol/Vodka 3 treatments q 15 minutes & repeat 6-8 hrs

Nebulized Furosemide Bronchodilatory effects Inhibition of irritant-receptors of the lung Rocker, Horton 2010 Inhibition of stretch receptors (vagal nerve) Shimoyama, JPSM 2002 Anti-inflamatory effect Prandota, Am J Ther mgs IV soln dye free per neb prn

Corticosteroids Dexamethasone Start 4 mgs bid and titrate up 24 mgs to 96 mgs/day IVP Solumedrol IVP 550 mgs qid Prednsone Start 40 mgs/day and titrate up

Benzos Are they effective? Breaks Anxiety-Dyspnea Cycle….prevalence of fear, anxiety, or panic? Short Acting preferred….Versed is the shortest No studies that show effectiveness in Advanced Cancer or ES COPD Cause more drowsiness than Morphine Use 2 nd line or in combination with Opiods Ativan Infusion 1-5 mg's/hr starts to accumulate in 3 days and may have to cutback

Opiods Nebulized Morphine does not work…studies too small Oral opiods work but with the usual side effects Lack of adverse effect on blood gasses Jennings, Thorax 2002 Do decrease the perception of Air Hunger & ↓ ventilatory response to ↓ O2 & ↑CO2 Cause vasodilation of pulmonary vessels: ↓ preload to the Heart Improve Dyspnea without causing Respiratory Depression Opiod Phobia

Opiod Responsive Dyspnea Parallels to opiod responsive and opiod non responsive type of pain Dyspnea may have varying degrees of opiod responsiveness dependent on several specific factors

Opiod Delivery ClassPreparationOnsetDuration Short Acting Morphine Hydromorphone Oxycodone Minutes 3-4 hours Long Acting Morphine SR Hydromorphone SR Oxycodone SR 3-4 Hours 8-12 hours Rapid Onset Fentanyl Oral Transmucosal Buccal Tablet Sublingual Tablet Intranasal Spray minutes 1-3 hours

Canadian Dyspnea Protocol StepsMedication# mcgs SL (50 mcg/ml) 1Fentanyl25 2Fentanyl50 3Sufentanil10 4Sufentanil15

Terminal Sectretions Non- pharmacologic Interventions – Reposition the patient first….basic Nursing Technique – Suction is rarely useful – Secretions re-accumulate rapidly & is overstimulating Anticholinergic / Antimuscarinics – 1% Atropine Opthalmic Gtts 4 gtts SL q 15mins X 4 then prn – Transdermal Scopolamine Patches – Robinol 0.2 mgs q 1 hr subQ/IVP If secretions become wet/rattling but not foamy -Atropine Aerosol 1mg with Albuterol 2.5 mgs q 4hrs prn